SlideShare a Scribd company logo
1 of 24
Biotech Boot Camp
Session 5 – Summary and wrap-up
Presenter: Nick Weston
Melbourne, Brisbane, Sydney
28 May – 18 June, 2014
• Summary
• Wrap-up
2
Session 5 Overview
Summary and wrap-up
• Summary
• Wrap-up
3
Session 5 Overview
Summary and wrap-up
• Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
4
Summary
• Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
5
Summary
• A payer-driven focus on outcomes is driving device
developers away from a focus on services delivered to an
emphasis on achieving measurable results in patient
health during entire episodes of care
• A move to simple inexpensive consumer technologies
that allow bypass of expensive and complex health
information systems and can be a tool for improving care
once patients are discharged from hospital
Biotechnology
6
Medical devices and diagnostics
• Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
7
Summary
• A shift from petroleum-based economy combined with the
exhaustion and soaring price of petroleum has resulted in
an increased consumer awareness in the environmental
impact of global warming (greenhouse gas, CO2 emission
and pollution)
• A move towards the development of renewable source-
based bio-process and the replacement of chemical
processes with bio-based ones
Biotechnology
8
Industrial applications and cleantech
• Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
9
Summary
• Next-generation sequencing and use of big-data
analytics will increasingly be considered in diagnoses
and treatment decisions
• Immunotherapies, gene therapies, stem cell therapies
and systems biology approaches are leading the charge
into the genomics era
Biotechnology
10
Life sciences
• Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
11
Summary
• A move away from traditional practice of cultivating the
soil, producing crops, and raising livestock, agriculture is
employing GM techniques to enhance traits of plants and
animals and increase the yield and productivity of crops
whilst protecting the environment from harm
• Agriculture and aquaculture are embracing biotechnology
advances and allowing further development of
biotechnological applications for use in medicines,
diagnostics and life sciences
Biotechnology
12
Agriculture and aquaculture
• Summary
• Wrap-up
13
Session 5 Overview
Summary and wrap-up
Biotechnology
14
Wrap-up – IPOs in 2013 by market segment
Source: Burrill Transforming Healthcare Report 2014
• 2013 best year fro biotech
since 2000
• Globally, 65 IPOs completed
• 7.5 billion raised
• In U.S. 52 companies raised 7
billion on IPO (cf. 2012 where 16
companies raised 1.1B)
Biotechnology
15
Wrap-up – companies are going public earlier
Source: Burrill Transforming Healthcare Report 2014
Examples:
• Epizyme (epigenetics) $88.7M
• Bluebird Bio (gene therapy)
$101M
• Stemline Therapeutics
(oncology stem cell) $38M
• OncoMed Pharmaceuticals
(oncology stem cell) $93.8M
Biotechnology
16
Wrap-up – it is not just human therapeutics doing well
*Source: Burrill Transforming Healthcare Report 2014
Examples:
• January 2013 – Zoetis, an animal health company (carved out of drug
maker Pfizer Inc.) raised about US$2.2 billion in an IPO
• May 2013 - Kamada, the maker of an inhalation device to treat the
rare disease alpha-1 antitrypsin deficiency, raised $59.9 million in a
Nasdaq IPO*
• June 2013 - Aratana Therapeutics, an animal health company raised
$57.5 million in a Nasdaq IPO
• November 2013 - Evogene, an ag-biotech focussed on developing
improved crop traits, raised $84.8 million in a NYSE IPO*
Biotechnology
17
Wrap-up – M&A in 2013 by market segment (U.S.)
Source: Burrill Transforming Healthcare Report 2014
Biotechnology
18
Wrap-up – Performance of top Australian companies in
2013
Source: Burrill Transforming Healthcare Report 2014
Biotechnology is a rapidly maturing and global sector
Where once it was dependent on passing muster with
regulators, its success is increasingly tied to payers
Deal-making remains highly active
Biotech companies have become subsumed into the
broader economy (energy markets, food security,
healthcare ecosystems) that they must understand to do
well
Biotechnology
19
Wrap-up
Biotechnology
20
Further resources
• http://www.ich.org/products/guidelines.html (these guidelines are
frequently referenced during the day development process, and
cover the manufacturing, nonclinical and clinical requirements;
use only some of parts of them depending on product)
• www.tga.gov.au (regulatory, Australia)
• www.fda.gov (regulatory, USA)
• www.fda.gov/MedicalDevices/ (medical devices regulatory, USA)
• www.ema.europa.eu/ema/ (regulatory, Europe)
• www.ausbiotech.org (Australia’s biotechnology industry
association)
Biotechnology
21
Further resources
• www.ncbi.nlm.nih.gov/ (access to biomedical and genomic
information at the U.S. National Center for Biotechnology
Information)
• www.ncbi.nlm.nih.gov/pubmed (subscription only publication
database for biomedical literature)
• www.australian-aquacultureportal.com/ (portal to Australian
aquaculture news and resources)
• www.nal.usda.gov/ (US Department of Agriculture’s National
Agricultural Library, the most comprehensive ag. resource)
• www.crops.org (website of the Crops Science Society of America,
news, publications, insights)
• www.ars.usda.gov/main/main.htm (US Gov. Agriculture Research
Service)
Biotechnology
22
Further resources
• www.biomelbourne.org/vicbioportal (lists Victorian companies
providing services to the sector)
• www.stemcellsaustralia.edu.au/ (resources on stem cell
technology)
• www.innovation.gov.au/industry/biotechnology/ (biotech related
resources and links)
• www.nhmrc.gov.au/ (Australia’s National Health and Medical
Research Council)
• www.biotechnologyonline.gov.au/ (Basic resource covering
Australian biotech sector and technologies)
Biotechnology
23
Further resources
• www.ipaustralia.gov.au/ (search engines for patents, designs and
trade mark registrations in Australia)
• www.wipo.int/portal/en/index.html (search engine for patents,
designs and trade mark registrations internationally)
• www.fiercebiotechresearch.com/ www.fiercebiotechresearch.com/
www.fiercebiotech.com/ www.fiercediagnostics.com/
www.fiercemedicaldevices.com/ (biotech sectoral news and
insights)
• www.buildingbiotechnology.com/ (starting, building and operating
a biotechnology business)
• www.fao.org/biotech/biotech-glossary/en/ (glossary of
biotechnology terms)
Nick Weston
T: +61 3 8616 0379
mail@nicholasweston.com
Viktoriia Hristova
T: +61 3 8616 0380
viktoriia@nicholasweston.com
www.nicholasweston.com
Wrap-up
24
THANK YOU

More Related Content

What's hot

Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular Diagnostics
EuroBioForum
 

What's hot (20)

VCLS microbiome workshop_short
VCLS microbiome workshop_shortVCLS microbiome workshop_short
VCLS microbiome workshop_short
 
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
 
Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular Diagnostics
 
HealthBIO 2020_Prateek Singh_Finnadvance
HealthBIO 2020_Prateek Singh_FinnadvanceHealthBIO 2020_Prateek Singh_Finnadvance
HealthBIO 2020_Prateek Singh_Finnadvance
 
Dr. William T. Flynn - FDA's New Efforts to Advance Antimicrobial Stewardship...
Dr. William T. Flynn - FDA's New Efforts to Advance Antimicrobial Stewardship...Dr. William T. Flynn - FDA's New Efforts to Advance Antimicrobial Stewardship...
Dr. William T. Flynn - FDA's New Efforts to Advance Antimicrobial Stewardship...
 
Industry
IndustryIndustry
Industry
 
1 photomedicine meeting-2019_bashaw-1br
1 photomedicine meeting-2019_bashaw-1br1 photomedicine meeting-2019_bashaw-1br
1 photomedicine meeting-2019_bashaw-1br
 
Controlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunitiesControlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunities
 
Global food safety Apr 2010
Global food safety Apr 2010Global food safety Apr 2010
Global food safety Apr 2010
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
This year's highlights and what's ahead for 2017
This year's highlights and what's ahead for 2017This year's highlights and what's ahead for 2017
This year's highlights and what's ahead for 2017
 
Safe Food, Fair Food: Reducing health risks from animal source foods
Safe Food, Fair Food: Reducing health risks from animal source foodsSafe Food, Fair Food: Reducing health risks from animal source foods
Safe Food, Fair Food: Reducing health risks from animal source foods
 
Exploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGAExploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGA
 
HealthBIO 2020 Aino Kalervo Tilt Biotherapeutics
HealthBIO 2020 Aino Kalervo Tilt BiotherapeuticsHealthBIO 2020 Aino Kalervo Tilt Biotherapeutics
HealthBIO 2020 Aino Kalervo Tilt Biotherapeutics
 
Evaluation of similar biotherapeutic products (sbps) scientific principles a...
Evaluation of similar biotherapeutic products (sbps)   scientific principles a...Evaluation of similar biotherapeutic products (sbps)   scientific principles a...
Evaluation of similar biotherapeutic products (sbps) scientific principles a...
 
Dr. Craig Lewis - FDA Activities Regarding Antimicrobial Resistance and Food-...
Dr. Craig Lewis - FDA Activities Regarding Antimicrobial Resistance and Food-...Dr. Craig Lewis - FDA Activities Regarding Antimicrobial Resistance and Food-...
Dr. Craig Lewis - FDA Activities Regarding Antimicrobial Resistance and Food-...
 
Legal framework 3 D food printing
Legal framework 3 D food printingLegal framework 3 D food printing
Legal framework 3 D food printing
 
Dr. Rick L. Sibbel - Antibiotic Stewardship
Dr. Rick L. Sibbel - Antibiotic StewardshipDr. Rick L. Sibbel - Antibiotic Stewardship
Dr. Rick L. Sibbel - Antibiotic Stewardship
 
The Role of Risk Assessment in Food Safety Systems
The Role of Risk Assessment in Food Safety SystemsThe Role of Risk Assessment in Food Safety Systems
The Role of Risk Assessment in Food Safety Systems
 
Overview of EU Regulatory Landscape for Regenerative Medicines
Overview of EU Regulatory Landscape for Regenerative MedicinesOverview of EU Regulatory Landscape for Regenerative Medicines
Overview of EU Regulatory Landscape for Regenerative Medicines
 

Viewers also liked (6)

Editing the BIOTECH Glossary with VocBench 1.1
Editing the BIOTECH Glossary with VocBench 1.1 Editing the BIOTECH Glossary with VocBench 1.1
Editing the BIOTECH Glossary with VocBench 1.1
 
PHARMACEUTICAL RELATED DEFINITIONS
PHARMACEUTICAL RELATED DEFINITIONS PHARMACEUTICAL RELATED DEFINITIONS
PHARMACEUTICAL RELATED DEFINITIONS
 
Anti-hypertensive drugs
Anti-hypertensive drugs Anti-hypertensive drugs
Anti-hypertensive drugs
 
Definitions and concepts
Definitions and conceptsDefinitions and concepts
Definitions and concepts
 
Biotech industry
Biotech industry Biotech industry
Biotech industry
 
Transfer pricing
Transfer pricingTransfer pricing
Transfer pricing
 

Similar to Nw biotech fundamentals day 2 session 5 summary and wrap up

Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and Healthcare
UNDP Eurasia
 
Bio technology parks
Bio technology  parksBio technology  parks
Bio technology parks
Jay Choudhary
 
Bio technology parks
Bio technology  parksBio technology  parks
Bio technology parks
Jay Choudhary
 
Btp a poc nanotechnology company.pptx
Btp a poc nanotechnology company.pptxBtp a poc nanotechnology company.pptx
Btp a poc nanotechnology company.pptx
Raouf Guirguis
 

Similar to Nw biotech fundamentals day 2 session 5 summary and wrap up (20)

Nw biotech fundamentals day 2 session 1 introduction
Nw biotech fundamentals day 2 session 1   introductionNw biotech fundamentals day 2 session 1   introduction
Nw biotech fundamentals day 2 session 1 introduction
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation Platform
 
Nurses No Harm
Nurses No HarmNurses No Harm
Nurses No Harm
 
Strategic decision making.pptx
Strategic decision making.pptxStrategic decision making.pptx
Strategic decision making.pptx
 
Biosimilars Presentation - Health Canada
Biosimilars Presentation - Health CanadaBiosimilars Presentation - Health Canada
Biosimilars Presentation - Health Canada
 
Biosimilars global congress 2014 europe copy 3 (6)
Biosimilars global congress 2014 europe  copy 3 (6)Biosimilars global congress 2014 europe  copy 3 (6)
Biosimilars global congress 2014 europe copy 3 (6)
 
Maheshwar, Chilukuri Challenges In Export And Import Of Temperature Control...
Maheshwar, Chilukuri   Challenges In Export And Import Of Temperature Control...Maheshwar, Chilukuri   Challenges In Export And Import Of Temperature Control...
Maheshwar, Chilukuri Challenges In Export And Import Of Temperature Control...
 
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE HealthcaremHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
 
Voluntary Certification Schemes working for Biodiversity
Voluntary Certification Schemes working for BiodiversityVoluntary Certification Schemes working for Biodiversity
Voluntary Certification Schemes working for Biodiversity
 
Food Safety Standards and Certifications.pptx
Food Safety Standards and  Certifications.pptxFood Safety Standards and  Certifications.pptx
Food Safety Standards and Certifications.pptx
 
Food Safety Standards and Certifications.pptx
Food Safety Standards and  Certifications.pptxFood Safety Standards and  Certifications.pptx
Food Safety Standards and Certifications.pptx
 
Alternative Proteins to Improve Health, Development and Environmental Outcomes
Alternative Proteins to Improve Health, Development and Environmental OutcomesAlternative Proteins to Improve Health, Development and Environmental Outcomes
Alternative Proteins to Improve Health, Development and Environmental Outcomes
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Food regulations
Food regulationsFood regulations
Food regulations
 
The regulation of biologicals in Australia
The regulation of biologicals in AustraliaThe regulation of biologicals in Australia
The regulation of biologicals in Australia
 
Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and Healthcare
 
Bio technology parks
Bio technology  parksBio technology  parks
Bio technology parks
 
Bio technology parks
Bio technology  parksBio technology  parks
Bio technology parks
 
Btp a poc nanotechnology company.pptx
Btp a poc nanotechnology company.pptxBtp a poc nanotechnology company.pptx
Btp a poc nanotechnology company.pptx
 
Socioeconomic considerations, biosafety and decision making: The view of a pr...
Socioeconomic considerations, biosafety and decision making: The view of a pr...Socioeconomic considerations, biosafety and decision making: The view of a pr...
Socioeconomic considerations, biosafety and decision making: The view of a pr...
 

More from Nicholas Weston Lawyers

More from Nicholas Weston Lawyers (9)

IP for Accountants Companion launch presentation
IP for Accountants   Companion launch presentationIP for Accountants   Companion launch presentation
IP for Accountants Companion launch presentation
 
Nw biotech fundamentals day 2 session 4 medical devices and diagnostics
Nw biotech fundamentals day 2 session 4   medical devices and diagnosticsNw biotech fundamentals day 2 session 4   medical devices and diagnostics
Nw biotech fundamentals day 2 session 4 medical devices and diagnostics
 
Nw biotech fundamentals day 2 session 3 agriculture and aquaculture
Nw biotech fundamentals day 2 session 3   agriculture and aquacultureNw biotech fundamentals day 2 session 3   agriculture and aquaculture
Nw biotech fundamentals day 2 session 3 agriculture and aquaculture
 
Nw biotech fundamentals day 2 session 2 industrial applications and cleantech
Nw biotech fundamentals day 2 session 2   industrial applications and cleantechNw biotech fundamentals day 2 session 2   industrial applications and cleantech
Nw biotech fundamentals day 2 session 2 industrial applications and cleantech
 
Nw biotech fundamentals day 1 session 5 life sciences
Nw biotech fundamentals day 1 session 5   life sciencesNw biotech fundamentals day 1 session 5   life sciences
Nw biotech fundamentals day 1 session 5 life sciences
 
Nw biotech fundamentals day 1 session 4 trends and techniques
Nw biotech fundamentals day 1 session 4   trends and techniquesNw biotech fundamentals day 1 session 4   trends and techniques
Nw biotech fundamentals day 1 session 4 trends and techniques
 
Nw biotech fundamentals day 1 session 3 regulatory
Nw biotech fundamentals day 1 session 3   regulatoryNw biotech fundamentals day 1 session 3   regulatory
Nw biotech fundamentals day 1 session 3 regulatory
 
Nw biotech fundamentals day 1 session 2 the business lifecycle of a biotech
Nw biotech fundamentals day 1 session 2   the business lifecycle of a biotechNw biotech fundamentals day 1 session 2   the business lifecycle of a biotech
Nw biotech fundamentals day 1 session 2 the business lifecycle of a biotech
 
Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612
 

Recently uploaded

Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
GOWTHAMIM22
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
jyothisaisri
 

Recently uploaded (20)

Developing Distributed High-performance Computing Capabilities of an Open Sci...
Developing Distributed High-performance Computing Capabilities of an Open Sci...Developing Distributed High-performance Computing Capabilities of an Open Sci...
Developing Distributed High-performance Computing Capabilities of an Open Sci...
 
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptxPOST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
 
Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
 
TEST BANK for Organic Chemistry 6th Edition.pdf
TEST BANK for Organic Chemistry 6th Edition.pdfTEST BANK for Organic Chemistry 6th Edition.pdf
TEST BANK for Organic Chemistry 6th Edition.pdf
 
MSCII_ FCT UNIT 5 TOXICOLOGY.pdf
MSCII_              FCT UNIT 5 TOXICOLOGY.pdfMSCII_              FCT UNIT 5 TOXICOLOGY.pdf
MSCII_ FCT UNIT 5 TOXICOLOGY.pdf
 
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxSaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
 
Triploidy ...............................pptx
Triploidy ...............................pptxTriploidy ...............................pptx
Triploidy ...............................pptx
 
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary Gland
 
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyanPlasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
 
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
 
In-pond Race way systems for Aquaculture (IPRS).pptx
In-pond Race way systems for Aquaculture (IPRS).pptxIn-pond Race way systems for Aquaculture (IPRS).pptx
In-pond Race way systems for Aquaculture (IPRS).pptx
 
Abortion uae unmarried price +27791653574 Contact Us Dubai Abu Dhabi Sharjah ...
Abortion uae unmarried price +27791653574 Contact Us Dubai Abu Dhabi Sharjah ...Abortion uae unmarried price +27791653574 Contact Us Dubai Abu Dhabi Sharjah ...
Abortion uae unmarried price +27791653574 Contact Us Dubai Abu Dhabi Sharjah ...
 
family therapy psychotherapy types .pdf
family therapy psychotherapy types  .pdffamily therapy psychotherapy types  .pdf
family therapy psychotherapy types .pdf
 
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday LifeGBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
 
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
 
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdfFORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
 
Introduction and significance of Symbiotic algae
Introduction and significance of  Symbiotic algaeIntroduction and significance of  Symbiotic algae
Introduction and significance of Symbiotic algae
 

Nw biotech fundamentals day 2 session 5 summary and wrap up

  • 1. Biotech Boot Camp Session 5 – Summary and wrap-up Presenter: Nick Weston Melbourne, Brisbane, Sydney 28 May – 18 June, 2014
  • 2. • Summary • Wrap-up 2 Session 5 Overview Summary and wrap-up
  • 3. • Summary • Wrap-up 3 Session 5 Overview Summary and wrap-up
  • 4. • Medical devices and diagnostics • Industrial applications and clean-tech • Life sciences • Aquaculture and agriculture Biotechnology 4 Summary
  • 5. • Medical devices and diagnostics • Industrial applications and clean-tech • Life sciences • Aquaculture and agriculture Biotechnology 5 Summary
  • 6. • A payer-driven focus on outcomes is driving device developers away from a focus on services delivered to an emphasis on achieving measurable results in patient health during entire episodes of care • A move to simple inexpensive consumer technologies that allow bypass of expensive and complex health information systems and can be a tool for improving care once patients are discharged from hospital Biotechnology 6 Medical devices and diagnostics
  • 7. • Medical devices and diagnostics • Industrial applications and clean-tech • Life sciences • Aquaculture and agriculture Biotechnology 7 Summary
  • 8. • A shift from petroleum-based economy combined with the exhaustion and soaring price of petroleum has resulted in an increased consumer awareness in the environmental impact of global warming (greenhouse gas, CO2 emission and pollution) • A move towards the development of renewable source- based bio-process and the replacement of chemical processes with bio-based ones Biotechnology 8 Industrial applications and cleantech
  • 9. • Medical devices and diagnostics • Industrial applications and clean-tech • Life sciences • Aquaculture and agriculture Biotechnology 9 Summary
  • 10. • Next-generation sequencing and use of big-data analytics will increasingly be considered in diagnoses and treatment decisions • Immunotherapies, gene therapies, stem cell therapies and systems biology approaches are leading the charge into the genomics era Biotechnology 10 Life sciences
  • 11. • Medical devices and diagnostics • Industrial applications and clean-tech • Life sciences • Aquaculture and agriculture Biotechnology 11 Summary
  • 12. • A move away from traditional practice of cultivating the soil, producing crops, and raising livestock, agriculture is employing GM techniques to enhance traits of plants and animals and increase the yield and productivity of crops whilst protecting the environment from harm • Agriculture and aquaculture are embracing biotechnology advances and allowing further development of biotechnological applications for use in medicines, diagnostics and life sciences Biotechnology 12 Agriculture and aquaculture
  • 13. • Summary • Wrap-up 13 Session 5 Overview Summary and wrap-up
  • 14. Biotechnology 14 Wrap-up – IPOs in 2013 by market segment Source: Burrill Transforming Healthcare Report 2014 • 2013 best year fro biotech since 2000 • Globally, 65 IPOs completed • 7.5 billion raised • In U.S. 52 companies raised 7 billion on IPO (cf. 2012 where 16 companies raised 1.1B)
  • 15. Biotechnology 15 Wrap-up – companies are going public earlier Source: Burrill Transforming Healthcare Report 2014 Examples: • Epizyme (epigenetics) $88.7M • Bluebird Bio (gene therapy) $101M • Stemline Therapeutics (oncology stem cell) $38M • OncoMed Pharmaceuticals (oncology stem cell) $93.8M
  • 16. Biotechnology 16 Wrap-up – it is not just human therapeutics doing well *Source: Burrill Transforming Healthcare Report 2014 Examples: • January 2013 – Zoetis, an animal health company (carved out of drug maker Pfizer Inc.) raised about US$2.2 billion in an IPO • May 2013 - Kamada, the maker of an inhalation device to treat the rare disease alpha-1 antitrypsin deficiency, raised $59.9 million in a Nasdaq IPO* • June 2013 - Aratana Therapeutics, an animal health company raised $57.5 million in a Nasdaq IPO • November 2013 - Evogene, an ag-biotech focussed on developing improved crop traits, raised $84.8 million in a NYSE IPO*
  • 17. Biotechnology 17 Wrap-up – M&A in 2013 by market segment (U.S.) Source: Burrill Transforming Healthcare Report 2014
  • 18. Biotechnology 18 Wrap-up – Performance of top Australian companies in 2013 Source: Burrill Transforming Healthcare Report 2014
  • 19. Biotechnology is a rapidly maturing and global sector Where once it was dependent on passing muster with regulators, its success is increasingly tied to payers Deal-making remains highly active Biotech companies have become subsumed into the broader economy (energy markets, food security, healthcare ecosystems) that they must understand to do well Biotechnology 19 Wrap-up
  • 20. Biotechnology 20 Further resources • http://www.ich.org/products/guidelines.html (these guidelines are frequently referenced during the day development process, and cover the manufacturing, nonclinical and clinical requirements; use only some of parts of them depending on product) • www.tga.gov.au (regulatory, Australia) • www.fda.gov (regulatory, USA) • www.fda.gov/MedicalDevices/ (medical devices regulatory, USA) • www.ema.europa.eu/ema/ (regulatory, Europe) • www.ausbiotech.org (Australia’s biotechnology industry association)
  • 21. Biotechnology 21 Further resources • www.ncbi.nlm.nih.gov/ (access to biomedical and genomic information at the U.S. National Center for Biotechnology Information) • www.ncbi.nlm.nih.gov/pubmed (subscription only publication database for biomedical literature) • www.australian-aquacultureportal.com/ (portal to Australian aquaculture news and resources) • www.nal.usda.gov/ (US Department of Agriculture’s National Agricultural Library, the most comprehensive ag. resource) • www.crops.org (website of the Crops Science Society of America, news, publications, insights) • www.ars.usda.gov/main/main.htm (US Gov. Agriculture Research Service)
  • 22. Biotechnology 22 Further resources • www.biomelbourne.org/vicbioportal (lists Victorian companies providing services to the sector) • www.stemcellsaustralia.edu.au/ (resources on stem cell technology) • www.innovation.gov.au/industry/biotechnology/ (biotech related resources and links) • www.nhmrc.gov.au/ (Australia’s National Health and Medical Research Council) • www.biotechnologyonline.gov.au/ (Basic resource covering Australian biotech sector and technologies)
  • 23. Biotechnology 23 Further resources • www.ipaustralia.gov.au/ (search engines for patents, designs and trade mark registrations in Australia) • www.wipo.int/portal/en/index.html (search engine for patents, designs and trade mark registrations internationally) • www.fiercebiotechresearch.com/ www.fiercebiotechresearch.com/ www.fiercebiotech.com/ www.fiercediagnostics.com/ www.fiercemedicaldevices.com/ (biotech sectoral news and insights) • www.buildingbiotechnology.com/ (starting, building and operating a biotechnology business) • www.fao.org/biotech/biotech-glossary/en/ (glossary of biotechnology terms)
  • 24. Nick Weston T: +61 3 8616 0379 mail@nicholasweston.com Viktoriia Hristova T: +61 3 8616 0380 viktoriia@nicholasweston.com www.nicholasweston.com Wrap-up 24 THANK YOU